2008
DOI: 10.1136/bmj.a2390
|View full text |Cite
|
Sign up to set email alerts
|

Improving the reporting of pragmatic trials: an extension of the CONSORT statement

Abstract: Background The CONSORT statement is intended to improve reporting of randomised controlled trials and focuses on minimising the risk of bias (internal validity). The applicability of a trial’s results (generalisability or external validity) is also important, particularly for pragmatic trials. A pragmatic trial (a term first used in 1967 by Schwartz and Lellouch) can be broadly defined as a randomised controlled trial whose purpose is to inform decisions about practice. This extension of the CONSORT statement … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
1,213
1
24

Year Published

2009
2009
2015
2015

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 1,460 publications
(1,259 citation statements)
references
References 69 publications
3
1,213
1
24
Order By: Relevance
“…To address these issues, two Consolidated Standards of Reporting Trials (CONSORT) statements have been developed describing reporting criteria for EHIs [10] and pragmatic trials [11] that provide guidance for study designs and evaluation methods, and reporting to inform decisions pertaining to both effectiveness and practical implementation of EHIs [12]. The Pragmatic Explanatory Continuum Indicator Summary (PRECIS) developed by the CON-SORT Work Group on pragmatic trials is designed to assist researchers in study design and assess a study along the pragmatic-explanatory continuum, a multidimensional continuum displaying varying levels of pragmatism across study dimensions of a particular trial [11,12].…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…To address these issues, two Consolidated Standards of Reporting Trials (CONSORT) statements have been developed describing reporting criteria for EHIs [10] and pragmatic trials [11] that provide guidance for study designs and evaluation methods, and reporting to inform decisions pertaining to both effectiveness and practical implementation of EHIs [12]. The Pragmatic Explanatory Continuum Indicator Summary (PRECIS) developed by the CON-SORT Work Group on pragmatic trials is designed to assist researchers in study design and assess a study along the pragmatic-explanatory continuum, a multidimensional continuum displaying varying levels of pragmatism across study dimensions of a particular trial [11,12].…”
mentioning
confidence: 99%
“…The Pragmatic Explanatory Continuum Indicator Summary (PRECIS) developed by the CON-SORT Work Group on pragmatic trials is designed to assist researchers in study design and assess a study along the pragmatic-explanatory continuum, a multidimensional continuum displaying varying levels of pragmatism across study dimensions of a particular trial [11,12]. PRECIS has been used to develop intervention trial design [13,14], to assess Implications Practice: Practitioners should look for and expect research reports to provide transparent information to make it possible to determine whether an eHealth program is possible to implement in their setting.…”
mentioning
confidence: 99%
“…Analyses were done in accordance with the CONSORT statement 27 and its extensions to cluster and pragmatic trials, 28,29 using SAS, version 9.3. 30 The unit of intervention was the PACT team, but the primary outcomes for the study were measured at the patient level, aggregated to the PCP.…”
Section: Resultsmentioning
confidence: 99%
“…30 This is a pragmatic two-arm parallel-group randomised controlled trial (RCT) with a feasibility phase. Formal stop-go criteria were established to assess the feasibility of the trial: (1) sufficient participants willing to enter the trial and (2) retention of sufficient participants to assess the primary outcome measure.…”
Section: Methods For the Main Trialmentioning
confidence: 99%